What's Actually Being Decided: Why Boards and Founders May Argue About the Wrong Number

Most strategic alternatives discussions begin the same way. A company has made real progress. Revenue is growing, customers are engaged, and management believes the business is approaching an inflection point. An acquisition offer arrives, or the tone in the boardroom begins to shift, and suddenly everyone is debating forecasts, market size, revenue multiples, and valuation. It looks like a discussion about what the company is worth. In my experience, it rarely is.

What's actually happening is that intelligent people are trying to solve different problems while using the same language. The founder is arguing for what the company could become while the board is asking whether it's worth the cost to find out. Those are not the same question. Until someone makes that distinction explicit, the discussion tends to generate more analysis than decisions.

Continuing to invest in a growth company is not simply an expression of confidence. It is a capital allocation decision. Every dollar committed today is a bet that the value created tomorrow will justify the investment required to get there. That's a fundamentally different question than asking what the business might someday be worth.

The question is no longer, What will this company be worth in three years?

The question is, What will it cost to build that future, how long will it take, and how likely is it that we actually get there?

These feel like variations on the same question. They are not. The first asks what an asset might become. The second asks whether the investment required to get there is justified given everything else that capital could do. One is a valuation exercise. The other is a capital allocation decision. They require different conversations, different analysis, and often lead to different conclusions.

Founders naturally spend their time thinking about what the business can become. That's the job. Boards spend their time deciding whether additional capital should be committed to help it get there. That's their job. Neither perspective is wrong. But they are different questions, and when that goes unacknowledged, people begin arguing about valuation when the disagreement is actually about something else entirely.

When a board's language shifts toward capital discipline and return thresholds, they are not asking for a better financial model or a more optimistic set of projections. They have quietly moved on to a different question, one the founder may not realize is already on the table.

The presenting problem and the real problem have separated.

Once that happens, more analysis rarely resolves the disagreement. Better forecasts don't help. Neither do more refined valuation models. Both sides simply become more confident in answers to different questions. That's why these discussions often feel surprisingly unproductive despite the quality of the people involved.

Two Different Companies, Same Language

Not every company occupies the same place on the map, and the right starting point depends entirely on which one is in the room.

Consider two businesses, each generating ten million dollars in revenue. The first is profitable, reinvesting its cash flow into growth, and can continue operating indefinitely without outside capital. The second is burning cash toward a critical milestone — a regulatory approval, a major contract, a product launch — that requires another financing round to reach. Both companies might be described as "growing." Both might receive identical acquisition offers. But they are not the same analytical problem, and treating them as if they were is where most of these conversations go wrong.

A profitable business that funds its own growth has a stable reference point. Valuing it as it exists today produces a meaningful baseline, and the capital allocation question comes after: should the company continue investing for growth, return capital to shareholders, pursue an acquisition, or explore a sale. Those are separate questions, asked in sequence.

A capital-dependent business doesn't offer that luxury. If the company requires another financing round to reach its next meaningful milestone, there is no stable as-is business sitting underneath the analysis. Business as usual isn't actually on the table. The value of the company depends on which capital path is taken. Will additional capital get raised. Will a strategic buyer emerge before cash runs out. Can management reach a meaningful de-risking milestone with what's left. Should the company pursue a structured transaction instead of another raise.

Until you've identified the capital path, there isn't a valuation to perform.

That's why a founder will often hear a board discussing return thresholds and assume confidence in the business has deteriorated. Usually that's not what's happening. The board has shifted from evaluating the business to evaluating the investment required to keep building it.

A Better Starting Point

The first step is to stop pretending there's a single answer waiting to be discovered. There isn't. The realistic alternatives may include another financing round, an immediate sale, one additional milestone before exploring a transaction, a recapitalization, or a strategic partnership. The important point isn't which path is chosen. It's making the paths explicit before trying to value them.

Each path carries a different capital requirement, timeline, probability of success, and expected outcome. Only once those alternatives are made explicit does valuation become useful. At that point the numbers stop trying to answer the wrong question and start comparing competing futures.

One final question deserves more attention than it usually gets: for whom is this the right answer?

The right answer for a founder with deep conviction and another decade to build may not be the right answer for an investor nearing the end of a fund's life. Different stakeholders often face different capital allocation problems. Acknowledging that doesn't create disagreement. It explains the disagreement that already exists.

The first job isn't financial modeling. It isn't valuation.

The first job is agreeing on the decision that's actually being made.